Just What Does a ‘Public Health Crisis’ Have to Do With Constitutionality of Gun Bans, Anyway?October 12, 2026
Lucas Q. Moore on October 12, 2026 11:42 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
Isabella G. Jackson on October 12, 2026 11:42 pm Interesting update on Dick Thompson’s First MACV-SOG Mission: Staring Down the Enemy & Death. Curious how the grades will trend next quarter. Reply
Patricia Brown on October 12, 2026 11:42 pm Exploration results look promising, but permitting will be the key risk. Reply
Linda Lee on October 12, 2026 11:42 pm Nice to see insider buying—usually a good signal in this space. Reply
Emma Brown on October 12, 2026 11:43 pm Nice to see insider buying—usually a good signal in this space. Reply
William Thomas on October 12, 2026 11:43 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Linda Thomas on October 12, 2026 11:43 pm Nice to see insider buying—usually a good signal in this space. Reply
Emma White on October 12, 2026 11:43 pm Silver leverage is strong here; beta cuts both ways though. Reply
Isabella Jones on October 12, 2026 11:43 pm I like the balance sheet here—less leverage than peers. Reply
Mary Lee on October 12, 2026 11:44 pm Silver leverage is strong here; beta cuts both ways though. Reply
Elijah Martinez on October 12, 2026 11:45 pm Silver leverage is strong here; beta cuts both ways though. Reply
Ava Jones on October 12, 2026 11:45 pm Interesting update on Dick Thompson’s First MACV-SOG Mission: Staring Down the Enemy & Death. Curious how the grades will trend next quarter. Reply
Elizabeth Martinez on October 12, 2026 11:48 pm Exploration results look promising, but permitting will be the key risk. Reply
Mary Williams on October 12, 2026 11:48 pm Exploration results look promising, but permitting will be the key risk. Reply
John Hernandez on October 12, 2026 11:48 pm Exploration results look promising, but permitting will be the key risk. Reply
Liam Martin on October 12, 2026 11:49 pm Interesting update on Dick Thompson’s First MACV-SOG Mission: Staring Down the Enemy & Death. Curious how the grades will trend next quarter. Reply
James Brown on October 12, 2026 11:51 pm Silver leverage is strong here; beta cuts both ways though. Reply
Oliver Rodriguez on October 12, 2026 11:52 pm If AISC keeps dropping, this becomes investable for me. Reply
Olivia Williams on October 12, 2026 11:52 pm Exploration results look promising, but permitting will be the key risk. Reply
Patricia Jackson on October 12, 2026 11:52 pm Exploration results look promising, but permitting will be the key risk. Reply
Emma Thompson on October 12, 2026 11:54 pm Exploration results look promising, but permitting will be the key risk. Reply
Olivia Brown on October 12, 2026 11:54 pm Exploration results look promising, but permitting will be the key risk. Reply
Jennifer Lopez on October 12, 2026 11:55 pm I like the balance sheet here—less leverage than peers. Reply
Elizabeth G. Johnson on October 13, 2026 12:20 am Good point. Watching costs and grades closely. Reply
Noah Thomas on October 12, 2026 11:55 pm Exploration results look promising, but permitting will be the key risk. Reply
By JackCarrUSA
By JackCarrUSA
By JackCarrUSA
51 Comments
Uranium names keep pushing higher—supply still tight into 2026.
Interesting update on Dick Thompson’s First MACV-SOG Mission: Staring Down the Enemy & Death. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on Dick Thompson’s First MACV-SOG Mission: Staring Down the Enemy & Death. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on Dick Thompson’s First MACV-SOG Mission: Staring Down the Enemy & Death. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.